Yahoo

FDA urges maker to recall Limbrel after liver and lung injury reports

The FDA lifted a clinical hold on Sarepta’s early-stage clinical trial for a gene therapy for Duchenne muscular dystrophy, putting the company's plans back on schedule. The Food and Drug ...
Capitalbolsa

Primus Announces A Voluntary Nationwide Recall Of All Lots Within Expiry Of Prescription Medical Food Limbrel® Due To Rare But Serious And Reversible Adverse Events While ...

SCOTTSDALE, Ariz., Jan. 26, 2018 /PRNewswire/ -- Primus Pharmaceuticals, Inc. of Scottsdale, Arizona is voluntarily recalling all unexpired lots of Limbrel products to the patient (user/consumer) ...
Becker's Hospital Review

Primus Pharma halts production, marketing of Limbrel in response to FDA safety concerns

Scottsdale, Ariz.-based Primus Pharmaceuticals took its osteoarthritis treatment Limbrel off the market at the FDA’s request, according to azcentral. While Primus markets Limbrel as a medical food, ...
Medical Xpress

Arthritis treatment linked to liver problems in study

(HealthDay) -- A "medical food" called Limbrel, which doctors prescribe to treat osteoarthritis of the knee, was linked to several cases of liver disease in a small study, but the effects so far seem ...
Reuters

‍U.S. FDA says is advising consumers not to use Limbrel

* ‍FDA - is issuing warning on use of Limbrel because of its investigation into a rise in cases of serious adverse events * ‍FDA says serious adverse events from use Limbrel include drug-induced liver ...